Althea Group Records growth across both arms of business
- Cannabis-based medicine supplier Althea Group (AGH) records growth across most key metrics in its two arms of business for the 2022 financial year
- The company grew its revenue by 77.8 per cent to $20.52 million and improved its cash outflows to $9.05 million
- Its Peak branch of business was the main driver of growth, with revenue lifting by 454 per cent to $8.9 million
- Despite the gains, AGH still recorded a loss of $12.12 million but this marked a 19.4 per cent improvement from the losses in the previous financial year
- Shares are trading steady at 9.6 cents at 1:52 pm AES
